Literature DB >> 19580785

Increased extracellular pressure provides a novel adjuvant stimulus for enhancement of conventional dendritic cell maturation strategies.

David H Craig1, Hiroe Shiratsuchi, Marc D Basson.   

Abstract

Dendritic cell (DC)-based vaccine strategies have gained increasing popularity in recent years. Methods for ex vivo generation of immunocompetent mature DCs still require optimization. DCs have been shown to phenotypically mature under elevated pressure. We compared the effects of pressure on DC maturation with LPS- and cytokine-stimulation. Human monocyte-derived immature or LPS- and cytokine-matured DCs were exposed to ambient or 40 mmHg increased pressure for 12h, then assessed for expression of CD80, CD86, CD40, MHC-I/II, and inflammatory cytokine production. DCs were also evaluated for capacity to stimulate T-cell proliferation by co-culture with allogeneic lymphocytes. Pressure significantly increased cytokine production and expression of all surface molecules on immature DC other than MHC-I and CD40. Pressure/LPS-treated DCs displayed further upregulation of MHC-I, CD40, and IL-12p70. Cytokine-matured DCs appeared less responsive to pressure. T-cell proliferation correlated with MHC expression. Results suggest mechanical stimulation of DCs may provide a useful adjuvant to TLR-agonist maturation strategies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19580785      PMCID: PMC3837574          DOI: 10.1016/j.bbrc.2009.07.010

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  22 in total

1.  Microbial compounds selectively induce Th1 cell-promoting or Th2 cell-promoting dendritic cells in vitro with diverse th cell-polarizing signals.

Authors:  Esther C de Jong; Pedro L Vieira; Pawel Kalinski; Joost H N Schuitemaker; Yuetsu Tanaka; Eddy A Wierenga; Maria Yazdanbakhsh; Martien L Kapsenberg
Journal:  J Immunol       Date:  2002-02-15       Impact factor: 5.422

Review 2.  Dendritic cells: development, function and potential use for cancer immunotherapy.

Authors:  D Avigan
Journal:  Blood Rev       Date:  1999-03       Impact factor: 8.250

3.  Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper function.

Authors:  Roman Spörri; Caetano Reis e Sousa
Journal:  Nat Immunol       Date:  2005-01-16       Impact factor: 25.606

Review 4.  Prospects for CD40-directed experimental therapy of human cancer.

Authors:  Alex W Tong; Marvin J Stone
Journal:  Cancer Gene Ther       Date:  2003-01       Impact factor: 5.987

Review 5.  Dendritic cells and the control of immunity.

Authors:  J Banchereau; R M Steinman
Journal:  Nature       Date:  1998-03-19       Impact factor: 49.962

6.  Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions.

Authors:  H Jonuleit; U Kühn; G Müller; K Steinbrink; L Paragnik; E Schmitt; J Knop; A H Enk
Journal:  Eur J Immunol       Date:  1997-12       Impact factor: 5.532

7.  Elevated physiologic tumor pressure promotes proliferation and chemosensitivity in human osteosarcoma.

Authors:  Saminathan S Nathan; Gene R DiResta; Jorge E Casas-Ganem; Bang H Hoang; Rebecca Sowers; Rui Yang; Andrew G Huvos; Richard Gorlick; John H Healey
Journal:  Clin Cancer Res       Date:  2005-03-15       Impact factor: 12.531

8.  Tumor cell loaded type-1 polarized dendritic cells induce Th1-mediated tumor immunity.

Authors:  David A Hokey; Adriana T Larregina; Geza Erdos; Simon C Watkins; Louis D Falo
Journal:  Cancer Res       Date:  2005-11-01       Impact factor: 12.701

9.  Activation of p38 MAPKalpha by extracellular pressure mediates the stimulation of macrophage phagocytosis by pressure.

Authors:  Hiroe Shiratsuchi; Marc D Basson
Journal:  Am J Physiol Cell Physiol       Date:  2004-12-29       Impact factor: 4.249

10.  Interstitial hypertension in superficial metastatic melanomas in humans.

Authors:  Y Boucher; J M Kirkwood; D Opacic; M Desantis; R K Jain
Journal:  Cancer Res       Date:  1991-12-15       Impact factor: 12.701

View more
  3 in total

1.  Biophysical and epigenetic regulation of cancer stemness, invasiveness and immune action.

Authors:  Praveen Krishna Veerasubramanian; Annie Trinh; Navied Akhtar; Wendy F Liu; Timothy L Downing
Journal:  Curr Tissue Microenviron Rep       Date:  2020-11-02

2.  Substrate stiffness influences phenotype and function of human antigen-presenting dendritic cells.

Authors:  Svenja F B Mennens; Matteo Bolomini-Vittori; Jorieke Weiden; Ben Joosten; Alessandra Cambi; Koen van den Dries
Journal:  Sci Rep       Date:  2017-12-13       Impact factor: 4.379

Review 3.  Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy.

Authors:  Yangfu Jiang; Hongying Zhang; Jiao Wang; Yongliang Liu; Ting Luo; Hui Hua
Journal:  J Hematol Oncol       Date:  2022-03-24       Impact factor: 17.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.